Kings Path Partners
AMGN icon

Kings Path Partners’s Amgen AMGN Stock Holding History

Kings Path Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.26K Hold
3
– – ﹤0.01% 331
2026
Q2 		$1.09K Buy
+3
New +$1.03K ﹤0.01% 317
2025
Q1 		– Sell
-3,789
Closed -$988K – 260
2024
Q4 		$988K Sell
3,789
-579
-13% -$172K 0.42% 61
2024
Q3 		$1.41M Hold
4,368
– – 0.59% 38
2024
Q2 		$1.36M Buy
+4,368
New +$1.28M 0.64% 36

Other funds holding AMGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Kings Path Partners's AMGN Position: Q3 2026 in Review

Kings Path Partners held its Amgen (AMGN) position steady in Q3 2026 at 3 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Kings Path Partners first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.41M in Q3 2024. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Kings Path Partners held 3 shares of Amgen worth $1.26K as of Q3 2026.
  • Kings Path Partners left its Amgen share count unchanged in Q3 2026.
  • Amgen made up ﹤0.01% of Kings Path Partners's portfolio in Q3 2026, its #331 holding.
  • Kings Path Partners first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • Kings Path Partners's Amgen position peaked at $1.41M in Q3 2024.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.